Muutke küpsiste eelistusi

Invasive Diagnostics and Therapy 1st ed. 2022 [Pehme köide]

  • Formaat: Paperback / softback, 119 pages, kõrgus x laius: 254x178 mm, kaal: 259 g, 1 Illustrations, black and white, 1 Paperback / softback
  • Sari: Advances in Experimental Medicine and Biology 1374
  • Ilmumisaeg: 02-Apr-2023
  • Kirjastus: Springer Nature Switzerland AG
  • ISBN-10: 3030988597
  • ISBN-13: 9783030988593
Teised raamatud teemal:
  • Pehme köide
  • Hind: 108,52 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 144,69 €
  • Säästad 25%
  • Raamatu kohalejõudmiseks kirjastusest kulub orienteeruvalt 3-4 nädalat
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Formaat: Paperback / softback, 119 pages, kõrgus x laius: 254x178 mm, kaal: 259 g, 1 Illustrations, black and white, 1 Paperback / softback
  • Sari: Advances in Experimental Medicine and Biology 1374
  • Ilmumisaeg: 02-Apr-2023
  • Kirjastus: Springer Nature Switzerland AG
  • ISBN-10: 3030988597
  • ISBN-13: 9783030988593
Teised raamatud teemal:

The book is an update on contentious or unsettled issues concerning invasive diagnostic and therapeutic challenges in cancer and related disorders, focusing on the surgical approach. 

Topics include recommendations for the best practice in using the surgery safety checklist, surgical strategies in a variety of thoracic cancers, renal cell carcinoma, tumors of parathyroid glands, mesothelioma, and bariatric surgeries. The focus is on the diagnostic and therapeutic challenges of aggressive cancerous entities, choosing the most beneficial modes for optimal outcomes and patient survival. Chapters also address radioimaging and therapy outcomes in different intracranial lesions leading to severe neurological disabilities. The areas of medical practice addressed are still veiled in uncertainty, yet-unresolved pathogenetic background, and have a substantial component of empirical rather than evidence-based clinical approach. Pursuing and sharing new ideas and innovations is essential for improving the management and outcome. 

The book endeavors to disseminate and deliberate on the latest medical knowledge, studies, and advancements in surgical and diagnostic dealing with cancer. The book is addressed to physicians and surgeons, and all allied health care professionals engaged in patient care and therapy.


Compliance with the Surgery Safety Checklist: An Update on the Status.-
Surgical Safety Checklist: Polychromatic or Achromatic Design.- Surgical
Strategy and Clinical Outcome in Patients with Bronchial Carcinoids.- Frozen
Section or Intraoperative Cytology: Are We Ready for a Paradigm Shift in
Thoracic Surgery?.- Clinical Outcome in Patients with Nosocomial COVID-19
Infection After Thoracic Surgery.- Cytological Diagnostic Procedures in
Malignant Mesothelioma.- Combination of Biochemical and Cytological Findings
for Better Diagnosis in Pleural Effusions.- Cytokines in Renal Cell
Carcinoma: A Step Towards Earlier Detection and Targeted Therapy.- Primary
Hyperparathyroidism Secondary to Ectopic Parathyroid Adenoma: A Case Report.-
Perception of Well-Being and Qualityof Life in Obese Patients After Bariatric
Surgery.- Do Multiple Brain Lesions Always Connote Worse Outcomes? Appraisal
Evidence from a Tertiary Care Center in Koshi/Purbanchal Province of Nepal.-
Radioimaging and Demographic Profiles of Patients with Spontaneous
Intracerebral Hemorrhage: A Need for the Pragmatic Referral System.-
Anticytokine Treatment of Rheumatoid Arthritis: An Observational Report.